The new coronavirus infection, despite severe respiratory complications, is accompanied by serious cardiovascular manifestations. A large proportion of patients have primary cardiovascular disease, which with COVID-19 increases the risk of heart com-plications. Objective. To analyze available data on cardiovascular disease and complications in patients with COVID-19. Results. Patients with severe inflammatory response syndrome and «cytokine storm», often accompanied by myocardial damage, are in the highest risk group. In the absence of proven pathogenetic therapy, supporting the treatment and identification of patients with high risk of heart complications is essential. Conclusion. The article describes the basic mechanisms of coronavirus SARS-CoV-2 exposure, the main clinical manifestations and possible mechanisms of heart complications in patients with COVID-19.